CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.04 HKD | +1.61% |
|
+5.22% | -1.75% |
| Apr. 24 | China Resources Pharmaceutical Group Limited Announces Change of Company Secretary | CI |
| Apr. 18 | China Resources Pharma Unit Issues 3 Billion Yuan Bonds | MT |
Chart calendar China Resources Pharmaceutical Group Limited
5c4819ef3ced50b7c4bc37a9e315080a._21wabJnOpkXPPAXZ1dfRAO0KVR8F4qSMu3ZfVNBJSg.mFlHUd4qad4vX8kgSj4xEEfwQz41XLrYAYmIImIKVhi9HTg54wBK0UgJlw~ef5d76925f6fa0a1b15c2e1ffec76aee
Upcoming events on China Resources Pharmaceutical Group Limited
Past events on China Resources Pharmaceutical Group Limited
| 2024-03-25 | Q4 2023 Earnings Call |
| 2024-03-25 | Q4 2023 Earnings Release |
| 2023-10-30 06:22 pm | Q3 2023 Earnings Release |
| 2023-08-30 | Q2 2023 Earnings Call |
| 2023-08-30 | Q2 2023 Earnings Release |
| 2023-03-29 | Q4 2022 Earnings Release |
| 2022-08-24 | Interim 2022 Earnings Release |
| 2022-05-26 10:30 pm | Annual General Meeting |
| 2022-03-28 | FY 2021 Earnings Release |
| 2021-08-24 | Interim 2021 Earnings Release |
| 2021-05-28 03:30 am | Annual General Meeting |
| 2021-03-25 | FY 2020 Earnings Release |
| 2020-08-26 | Interim 2020 Earnings Release |
| 2020-03-29 | FY 2019 Earnings Release |
| 2019-08-25 | Interim 2019 Earnings Release |
| 2019-03-20 | FY 2018 Earnings Release |
| 2018-08-23 | Interim 2018 Earnings Release |
| 2018-03-20 | FY 2017 Earnings Release |
| 2017-10-26 | Deutsche Bank dbAccess China Healthcare Corporate Day |
| 2017-08-23 | Interim 2017 Earnings Release |
Past dividends on China Resources Pharmaceutical Group Limited
| 2023-06-04 | Annual 0.16 HKD |
| 2022-06-05 | Annual 0.15 HKD |
| 2021-06-01 | Annual 0.12 HKD |
| 2020-06-28 | Annual 0.11 HKD |
| 2019-06-02 | Annual 0.13 HKD |
| 2018-05-22 | Annual 0.11 HKD |
| 2017-05-23 | Annual 0.09 HKD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million HKD | Released Forecast Spread | 204 454 205 185 -0.36% | 200 423 211 379 -5.18% | 236 806 235 143 0.71% | 254 106 263 071 -3.41% | 244 704 280 839 -12.87% | 280 147 |
|
EBITDA Million HKD | Released Forecast Spread | 12 576 13 130 -4.22% | 11 790 11 920 -1.09% | 12 690 13 221 -4.01% | 16 775 14 256 17.67% | 14 191 15 890 -10.69% | 16 327 |
|
EBIT Million HKD | Released Forecast Spread | 10 212 12 155 -15.99% | 9 346 10 259 -8.89% | 9 868 11 648 -15.28% | 13 623 12 050 13.05% | 11 027 13 281 -16.97% | 13 492 |
|
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 6 640 9 426 -29.56% | 7 076 7 311 -3.23% | 8 408 8 897 -5.49% | 9 856 9 918 -0.63% | 9 880 11 112 -11.09% | 11 553 |
|
Net income Million HKD | Released Forecast Spread | 3 286 4 254 -22.74% | 3 297 3 538 -6.8% | 3 769 3 725 1.17% | 4 147 4 380 -5.3% | 3 854 4 510 -14.53% | 4 565 |
|
EPS HKD | Released Forecast Spread | 0,52 0,67 -21.97% | 0,52 0,56 -7.59% | 0,60 0,59 1.32% | 0,66 0,70 -5.3% | 0,61 0,72 -15.02% | 0,71 |
| Announcement Date | 30/03/20 | 26/03/21 | 29/03/22 | 30/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million HKD | Released Forecast Spread | 102 531 102 997 -0.45% | 89 387 108 446 -17.57% | 111 036 120 729 -8.03% | 114 488 108 355 5.66% | 122 319 117 790 3.84% | 125 716 128 356 -2.06% | 128 390 134 469 -4.52% | 138 940 137 924 0.74% | 105 764 136 356 -22.44% | 143 431 | 128 098 | 159 867 | 143 329 |
|
EBITDA Million HKD | Released Forecast Spread | 4 573 5 589 -18.17% | ||||||||||||
|
EBIT Million HKD | Released Forecast Spread | 3 711 3 668 1.17% | 6 481 7 072 -8.36% | 4 058 5 044 -19.55% | 7 822 6 108 28.06% | 5 801 4 741 22.36% | 7 745 7 246 6.89% | 3 282 5 141 -36.15% | 8 373 | 5 151 | 9 600 | 5 171 | ||
|
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 2 586 2 277 13.56% | 7 117 6 581 8.14% | 2 763 4 628 -40.29% | ||||||||||
|
Net income Million HKD | Released Forecast Spread | 720 919 -21.66% | 3 038 3 196 -4.94% | 816 | ||||||||||
|
EPS HKD | Released Forecast Spread | 0,04 -0,03 233.33% | 0,41 0,43 -4.65% | 0,11 0,15 -26.67% | 0,39 0,46 -15.22% | 0,21 0,22 -4.55% | 0,48 0,38 26.32% | 0,18 0,23 -21.74% | 0,13 0,20 -35% | 0,48 | 0,20 | 0,55 | 0,18 | |
| Announcement Date | 30/03/20 | 27/08/20 | 26/03/21 | 25/08/21 | 29/03/22 | 25/08/22 | 30/03/23 | 31/08/23 | 26/03/24 | - | - | - | - |
More events
Past sector events for China Resources Pharmaceutical Group Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 3320 Stock
- Calendar China Resources Pharmaceutical Group Limited
